Aurobindo Pharma (Sterile Injectables Division)

Hyderabad, India
Sterile Injectables Lyophilized Vials Biologics (emerging) Small Molecule Injectable Terminal Sterilization
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: Aurobindo Pharma (Sterile Injectables Division)

Signal Score
60.0/100
Quality Compliance
Assessment pending
Headquarters
Hyderabad, India
Modalities
Sterile Injectables, Lyophilized Vials, Biologics (emerging), Small Molecule Injectable, Terminal Sterilization
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Aurobindo Pharma (Sterile Injectables Division)

Auto-created by AI matchmaker. Data verification pending.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesSterile Injectables, Lyophilized Vials, Biologics (emerging), Small Molecule Injectable, Terminal Sterilization
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 60.0
Broad modality coverage (5 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Broad modality coverage (5 modalities)

Frequently Asked Questions About Aurobindo Pharma (Sterile Injectables Division)

What is Aurobindo Pharma (Sterile Injectables Division)'s CDMO Signal Score?
Aurobindo Pharma (Sterile Injectables Division) has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Aurobindo Pharma (Sterile Injectables Division) for a manufacturing program?
Use the free AI matchmaker to compare Aurobindo Pharma (Sterile Injectables Division) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Biologics (emerging) CDMOs →

Similar CDMOs

Sun Pharmaceutical Industries Ltd.
Mumbai, India
Small Molecule API, Oral Solid Dose, Sterile Injectables, Specialty Generics, Novel Chemical Entities (NCE) via CRAMS, Biologics (via CMO partnerships), Specialty/Innovative Medicines
Otsuka Pharmaceutical Factory (OPF)
Naruto, Tokushima, Japan
IV Solutions / Infusion Products, Sterile Injectables, Soft Bags / Premixed Bags, Small-Capacity Plastic Ampoules, Oral Rehydration Solutions, Semi-solids (Ointments, Creams), Antibiotic Kits (Multi-chamber Bag System)